University of Southampton
Role of the Akt signalling pathway in CD8 T cell immune response
Abstract
dc:description.abstractUnderstanding the signalling pathways controlling activation and differentiation of CD8 T cells will facilitate their exploitation for anti-cancer therapy. The Akt/PKB signalling pathway influences CD8 T cell function and differentiation but published data are discrepant. Utilising a PDKK465E knock-in mutant mouse model, in which T cells exhibit impaired Akt activity, data presented here show that sub-optimal Akt activity limits CD8 T cell IFN-γ and IL-2 production, granzyme B expression and cellular cytotoxicity. Additional chemical inhibition of Akt further hindered cytotoxicity and granzyme B expression. Microarray and confirmatory qPCR showed reduced expression of transcripts encoding the membrane trafficking protein BAIAP3 in PDKK465E cells which may be responsible for some of these effects.<br/>Previous data from the group showed that PDKK465E CD8 T cells have a skewed memory population. Here single cell RNA sequencing and unsupervised clustering was used to define 7 cell subsets at the peak of Listeria Monocytogenes infection and in which a memory precursor effector cell-like phenotype was favoured by PDKK465E cells. Additionally, mRNA encoding ribosomal proteins was enriched in PDKK465E compared with WT CD8 T cells, and also in more memory-like cells across both samples. PDKK465E cells also exhibited enrichment in OXPHOS-related transcripts, a feature previously correlated with a memory phenotype.<br/>Use of PDKK465E mutant cells, pharmacological inhibition (Akti) and a constitutive form of Akt (Myr-Akt), allowed further examination of effects of altered Akt activity on oxidative phosphorylation. These data showed no significant improvement in spare respiratory capacity (SRC) in Akt-inhibited WT CD8 T cells cultured in IL-2 although Akt inhibition in PDKK465E CD8 T cells resulted in a significant improvement in SRC. Enforced Akt activity in CD8 T cells cultured in IL-15 reduced SRC. However, SRC remained higher than IL-2-treated cells, indicating that whilst increased Akt activity impairs oxidative phosphorylation, there are aspects of IL-15 signalling that cannot be overcome by constitutive Akt activity. Despite a beneficial metabolic and cytotoxic profile, Myr-Akt transduced IL-15 treated CD8 T cells were only marginally superior to IL-15 treated controls cells at conferring tumour therapy.<br/>SGK1, a kinase sharing homology with Akt, was also examined for its effects in CD8 T cells. Under stimulation with normal or restrictive concentrations of IL-2, pharmacological inhibition of SGK1 had negative effects on cellular proliferation. Further, stimulation of SGK1 through increased NaCl concentrations in culture media caused increased survival of CD8 T cells in both cytokine replete and limiting conditions.<br/>Together the data presented in this thesis show that reduced Akt signalling causes a defect in the cytotoxic capacity of CD8 T cells in vitro and alters the transcriptome of CD8 T cells at the peak of an immune response, inducing a more MPEC phenotype. In addition, new subsets of CD8 T cells were identified through Drop-Seq. Mitochondrial oxidative phosphorylation was shown to be negatively regulated by Akt activity. Lastly, SGK1 was shown to increase survival and proliferation of CD8 T cells. These data have implications for CD8 T cell differentiation and treatments aimed at manipulating Akt for therapeutic benefit.
Degree
thesis:*- Name dc:type.qualificationname
- Ph.D.
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- University of Southampton
- Year dc:date.issued
- 2018
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Bailey, Thomas
- Advisors dc:contributor.advisor
-
- Al-Shamkhani, Aymen
- Buchan, Sarah L
- ORCID person:identifier.orcid
Rights
- Language dc:language
- English, eng